中国癌症杂志 ›› 2016, Vol. 26 ›› Issue (6): 521-526.doi: 10.19401/j.cnki.1007-3639.2016.06.007

• 论著 • 上一篇    下一篇

影像组学应用于肝脏特征分析及其预测治疗反应的初步研究

夏 凡,胡盼盼,王佳舟,胡伟刚,李桂超,章 真   

  1. 复旦大学附属肿瘤医院放疗科,复旦大学上海医学院肿瘤学系,上海 200032
  • 出版日期:2016-06-30 发布日期:2016-07-28
  • 通信作者: 章 真 E-mail: zhenzhang6@hotmail.com

Application of radiomics approach for decoding normal liver features and predicting chemotherapyassociated liver injury: A preliminary study

XIA Fan, HU Panpan, WANG Jiazhou, HU Weigang, LI Guichao, ZHANG Zhen   

  1. Department of Radiation Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2016-06-30 Online:2016-07-28
  • Contact: ZHANG Zhen E-mail: zhenzhang6@hotmail.com

摘要: 背景与目的:影像组学通过挖掘影像特征数据对组织特性进行判断,预测组织对治疗的反应和患者的预后。该研究旨在探索运用影像组学方法评估肝脏组织特征,以及预测化疗后肝功能异常的可行性。方法:回顾性收集胃癌患者化疗前腹部CT平扫图像,勾画全部肝脏,利用影像组学方法提取图像特征值并进行聚类分析。采用Pearson χ2检验分析聚类结果与患者临床特征的相关性,以及其与化疗后肝功能异常发生的相关性。结果:73例患者根据其图像特征聚类为两组,两组间性别构成比差异有统计学意义(P=0.004)。两组化疗后肝功能异常的发生率为48.7%和67.6%,相差为18.9%。临床参数如年龄、性别、化疗给药途径、化疗周期数、HBV感染史、化疗前血清HBsAg状态与化疗后肝功能异常发生率均无显著相关性。影像组学聚类分析预测,化疗后肝功能异常的准确性为0.59。结论:影像组学分析结果反应了不同性别人群肝脏影像学特征的差异,并可能有助于预测化疗后肝功能异常。影像组学用于评估肝脏组织特征以及预测治疗相关不良反应是可行的。

关键词: 影像组学, 肝脏, 聚类, 性别, 化疗相关肝损伤

Abstract: Background and purpose: Radiomics refers to the comprehensive quantification of human tissues through assessing a large number of quantitative image features. Radiomics approach is used to decode tumor phenotypes and predict treatment outcomes. Here we present a study investigating radiomic analysis to assess normal liver features and predict chemotherapy-associated liver injury. Methods: Gastric cancer patients treated with surgery and adjuvant chemotherapy were enrolled in this study retrospectively. CT images were obtained before chemotherapy. The whole liver organ was delineated by radiation oncologists. Images were extracted and filtered by radiomic approach to extract radiomic features. Clustering was performed to reveal clusters of patients with similar radiomic expression patterns. Chi-squared tests were used to assess the association of radiomic data with clinical data and chemotherapy-related liver injury. Results: Radiomic features of 73 patients were clustered into two clusters. A significant association with gender (P=0.004, chi-squared test) was observed, where in male showed a higher presence in cluster Ⅰ. Incidence of abnormal liver function after chemotherapy was 48.7% in cluster I and 67.6% in cluster Ⅱ, respectively (Δ=18.9%). Clinical data including age, gender, chemotherapy modality, number of chemotherapy cycles, HBV infection history, HBs-antigen presence were not associated with liver function abnormalities after chemotherapy. Accuracy of radiomic analysis to predict liver injury is 0.59. Conclusion: Radiomic approach revealed different imaging features of liver between men and women. It could help to predict chemotherapy-associated liver injury. It is feasible to use radiomics approach to decode normal liver features and predict treatment-associated liver injury.

Key words: Radiomics, Liver, Cluster, Gender, Chemotherapy-associated liver injury